Himalaya Therapeutics

Himalaya is a majority owned subsidiary of BioAtla, Inc. and a Cayman Island corporation. Himalaya has the exclusive license from BioAtla to develop and commercialize several specific CAB candidates for the Greater China market of the PRC,